Search results for “Thymidine Phosphorylase Deficiency” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 90 patents, we discovered top 21 key players by total patent application. Taiho Pharmaceutical Co., Ltd., Wellcome Foundation Ltd, Delta Biotechnology Ltd. are dominant in this area. They take 58.89% of the total patent filing.
Taiho Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 25
Wellcome Foundation Ltd
United Kingdom
Patent: 19
Delta Biotechnology Ltd.
NOTTINGHAM, United Kingdom
Patent: 9
Entrada Therapeutics, Inc.
Massachusetts, United States
Patent: 5
Shuttle Pharmaceuticals, Inc.
United States
Patent: 4
Industrial Research Ltd.
WELLINGTON, New Zealand
Patent: 4
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 3
Nanjing Nuoyun Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Burroughs Wellcome & Co. (U.S.A.), Inc.
New York, United States
Patent: 3
SCM Lifescience Co., Ltd.
South Korea
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 15 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Entrada Therapeutics, Inc., Shuttle Pharmaceuticals, Inc., Marshall University Research Corp. take 80.00% of patent filing during this period.
Entrada Therapeutics, Inc.
Massachusetts, United States
Patent: 5
Shuttle Pharmaceuticals, Inc.
United States
Patent: 4
Marshall University Research Corp.
West Virginia, United States
Patent: 3
Aeglea Biotherapeutics, Inc.
Texas, United States
Patent: 1
Asymchem Laboratories (Tianjin) Co., Ltd.
Tianjin Shi, China
Patent: 1
Tianjin Lakeside Pangu gene science development Company Limited
Tianjin Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 15 patents in last 5 years, we discover 6 new entrants. Entrada Therapeutics, Inc., Shuttle Pharmaceuticals, Inc., Marshall University Research Corp. are the most active new entrants in this area.
Entrada Therapeutics, Inc.
Massachusetts, United States
Patent: 5
Shuttle Pharmaceuticals, Inc.
United States
Patent: 4
Marshall University Research Corp.
West Virginia, United States
Patent: 3
Aeglea Biotherapeutics, Inc.
Texas, United States
Patent: 1
Asymchem Laboratories (Tianjin) Co., Ltd.
Tianjin Shi, China
Patent: 1
Tianjin Lakeside Pangu gene science development Company Limited
Tianjin Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 35 patents, we discovered top 9 universities and scientific research institutions by total patent application. University of Southern California, The Hong Kong Polytechnic University, Albert Einstein College of Medicine, Inc. are dominant in this area. They take 42.86% of the total patent filing.
University of Southern California
California, United States
Patent: 5
The Hong Kong Polytechnic University
Hong Kong SAR, China
Patent: 3
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 3
Hokkaido University
Hokkaido, Japan
Patent: 2
Yeshiva University
New York, United States
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Yunnan University
Yunnan Sheng, China
Patent: 1
University of Shanghai for Science & Technology
Shanghai Shi, China
Patent: 1
Qingdao Agriculture University
Shandong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: